On this page
Myoclonus-dystonia (DYT11)
This condition typically begins in childhood or adolescence, affecting movement and sometimes leading to associated non-motor symptoms. It is caused by genetic changes, most commonly in the SGCE gene, and is inherited in an autosomal dominant manner.
Overview
Myoclonus-dystonia (DYT11) is a neurological condition where individuals experience two main types of involuntary movements: myoclonus and dystonia. Myoclonus refers to sudden, brief, shock-like muscle jerks, while dystonia involves sustained or repetitive muscle contractions that can cause twisting or abnormal postures [PMID:33671239]. These symptoms most commonly affect the upper body, such as the neck, arms, and trunk, and can vary in severity between individuals. This condition is also termed DYT-SGCE dystonia after its primary genetic cause.
Symptoms typically emerge during childhood or adolescence, though onset can occur later in some cases. The movements can be made worse by stress, anxiety, or voluntary movements, but often improve with alcohol consumption, which is a characteristic feature for some individuals [PMID:17912443]. Myoclonus-dystonia is considered a rare condition, and its exact prevalence is not well established. Beyond movement issues, some people with Myoclonus-dystonia may experience non-motor symptoms like anxiety, depression, or obsessive-compulsive behaviours.
Symptoms & clinical features
The primary symptoms of Myoclonus-dystonia are myoclonus and dystonia. Myoclonus typically presents as quick, jerky movements, often affecting the upper limbs, neck, and trunk. These movements can interfere with daily activities such as writing, eating, or dressing. Dystonia in DYT11 is generally milder and may involve sustained muscle contractions, leading to postures such as a twisted neck (torticollis) or writer's cramp.
Symptoms often worsen with stress, fatigue, or attempting precise movements. Paradoxically, alcohol intake may temporarily reduce the severity of movement symptoms for some individuals, which can sometimes lead to an incorrect assumption of alcohol dependence [PMID:17912443]. Beyond movement difficulties, individuals with Myoclonus-dystonia may also experience non-motor symptoms. These can include anxiety disorders, depression, panic attacks, and obsessive-compulsive disorder (OCD). These psychiatric symptoms can sometimes be as impactful on an individual's life as the movement disorder itself.
Video: Genetics 101
Affected organs
Myoclonus-dystonia primarily affects the nervous system, specifically the parts of the brain that control movement. This leads to the characteristic involuntary muscle movements of myoclonus and dystonia. While the condition doesn't directly damage other organs, the neurological dysfunction impacts the control of skeletal muscles throughout the body, particularly those in the upper limbs, neck, and trunk.
The brain regions involved in motor control, such as the basal ganglia and cerebellum, are thought to be implicated in the development of symptoms. Additionally, the association with psychiatric symptoms suggests that broader brain circuits involved in mood and behaviour can also be affected in some individuals.
Risks & severity
The severity of Myoclonus-dystonia symptoms can vary significantly, even within the same family. Some individuals may experience mild, occasional jerks, while others might have more persistent and debilitating movements that significantly affect their quality of life. The condition typically manifests in childhood or adolescence, with onset usually before the age of 20, but later onset has been reported. Symptoms tend to be progressive in the early stages, often stabilising in adulthood, though fluctuations can occur.
While Myoclonus-dystonia is not considered life-threatening, its symptoms can impact daily functioning, education, and employment. The associated psychiatric symptoms, such as anxiety and depression, also contribute to the overall burden of the condition and can require specific management. Genetic testing allows for a definitive diagnosis and can provide information for family planning, though it does not predict symptom severity.
Genetic causes
Myoclonus-dystonia is most commonly caused by pathogenic variants in the SGCE gene [PMID:33671239]. The SGCE gene provides instructions for making a protein called sarcoglycan epsilon. This protein is part of a complex of proteins found in the membrane of muscle cells and nerve cells. In nerve cells, sarcoglycan epsilon is thought to play a role in how nerve cells communicate with each other, particularly in areas of the brain involved in controlling movement.
When a pathogenic variant occurs in the SGCE gene, it can lead to a dysfunctional or absent sarcoglycan epsilon protein. This disruption in protein function is believed to impair the normal signalling between nerve cells, leading to the uncontrolled muscle movements characteristic of Myoclonus-dystonia. Other genes have also been implicated in some cases of Myoclonus-dystonia, but SGCE is the most frequent genetic cause.
- SGCE sarcoglycan epsilon
Inheritance pattern
Myoclonus-dystonia typically follows an autosomal dominant pattern of inheritance. This means that an individual only needs one copy of the altered gene in each cell to develop the condition. In most cases, a person inherits the pathogenic variant from an affected parent. However, in some instances, the genetic change can occur spontaneously (a de novo variant) in the affected individual, with no family history of the condition.
Because Myoclonus-dystonia is inherited in an autosomal dominant manner, each child of an affected parent has a 50% chance of inheriting the pathogenic variant and therefore the condition. It's important to note that even if a person inherits the variant, the severity of symptoms can vary widely, a phenomenon known as variable expressivity. This means some individuals with the variant may have very mild symptoms, while others have more significant ones. Due to a phenomenon called genomic imprinting, the SGCE gene is typically only expressed when inherited from the father. If a pathogenic variant is inherited from the father, symptoms are usually present. However, if the pathogenic variant is inherited from the mother, symptoms are often not present or are much milder, because the maternal copy of the gene is typically silenced.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
The diagnosis of Myoclonus-dystonia is initially based on clinical signs and symptoms, including the characteristic combination of myoclonus and dystonia, often with improvement after alcohol consumption. A detailed medical history, neurological examination, and assessment for associated psychiatric symptoms are crucial.
Confirmation of the diagnosis involves genetic testing to identify pathogenic variants in the SGCE gene or other relevant genes. In the UK, individuals suspected of having a rare genetic condition like Myoclonus-dystonia can be referred to Clinical Genetics services through the NHS Genomic Medicine Service (GMS). Genetic testing is typically performed under an NHS R-code, such as R86 (Dystonia) or R102 (Movement disorder - gene panel), following a clinical assessment by a specialist neurologist or clinical geneticist. Genetic counselling is an integral part of this process, offering support and information to individuals and their families.
Management & lifestyle
While there is currently no cure for Myoclonus-dystonia, management focuses on alleviating symptoms and improving quality of life. Treatment approaches are individualised based on the specific symptoms and their severity. Medications such as clonazepam or other benzodiazepines can help reduce myoclonus for some individuals. Other drugs, including anticholinergics or dopamine agonists, may be considered for dystonia symptoms.
For more localised dystonia, botulinum toxin injections can be effective. Non-pharmacological treatments, such as physiotherapy and occupational therapy, can help maintain mobility, improve function, and manage daily challenges. For associated psychiatric symptoms like anxiety and depression, psychological therapies and appropriate medications can be beneficial. Individuals with Myoclonus-dystonia should be managed by a multidisciplinary team, typically including neurologists, geneticists, psychiatrists, and allied health professionals, within the NHS framework.
UK care pathway
In the UK, individuals with suspected Myoclonus-dystonia will generally be referred by their GP or another specialist to an NHS neurologist for assessment. If a genetic cause is suspected, referral to a Clinical Genetics service is the next step within the NHS Genomic Medicine Service (GMS). Genetic counsellors within these services provide essential support, explaining the condition, inheritance patterns, and the implications of genetic testing. Genetic testing for Myoclonus-dystonia typically falls under specific R-codes for movement disorders or dystonias within the GMS, ensuring access to appropriate diagnostic pathways.
Frequently asked questions
Will my children inherit Myoclonus-dystonia?
Myoclonus-dystonia is inherited in an autosomal dominant pattern. If one parent has a pathogenic SGCE variant, each child has a 50% chance of inheriting it. However, due to genomic imprinting, if the variant is inherited from the mother, symptoms are often absent or much milder because the maternal copy of the gene is typically silenced.
Can alcohol help my symptoms?
Some individuals with Myoclonus-dystonia report a temporary reduction in movement symptoms after consuming alcohol. This is a characteristic feature for some, but it is not a recommended long-term treatment strategy due to potential health risks associated with regular alcohol use.
Are there non-movement symptoms associated with Myoclonus-dystonia?
Yes, many individuals with Myoclonus-dystonia also experience non-motor symptoms, including anxiety, depression, panic attacks, and obsessive-compulsive disorder (OCD). These symptoms are an important part of the condition and should be addressed in management.
When do symptoms of Myoclonus-dystonia usually start?
Symptoms of Myoclonus-dystonia typically begin during childhood or adolescence, often before the age of 20. However, there can be variability, and some individuals may experience a later onset of symptoms.
Is there a cure for Myoclonus-dystonia?
Currently, there is no cure for Myoclonus-dystonia. Management focuses on treating the symptoms to improve quality of life. This can involve medications, therapies, and addressing associated non-motor symptoms.